Key result
Newly onset acute coronary syndrome in managed care patients incurred substantial costs, averaging $2,312 per patient-month over 12 months of follow-up, with 72% attributable to hospitalizations.
Why the study?
What are the total first-year costs and healthcare utilization patterns following newly onset acute coronary syndrome in a managed care setting?
Cohort (n=13,731)
What are the total first-year costs and healthcare utilization patterns following newly onset acute coronary syndrome in a managed care setting?
Newly onset acute coronary syndrome in managed care patients incurs substantial first-year costs, primarily driven by hospitalizations, with potential gaps in post-ACS medical therapy.
No takes yet. Share an insight, caveat, or question.
High first-year ACS costs in managed care, driven by hospitalizations; leaves open whether modern therapies reduce this burden.
Etemad et al. (2005) conducted a cohort in Acute Coronary Syndrome (n=13,731). Newly onset acute coronary syndrome was evaluated on Total cost of health care utilization (health plan plus patient) in the 12-month period following newly onset ACS. Newly onset acute coronary syndrome in managed care patients incurred substantial costs, averaging $2,312 per patient-month over 12 months of follow-up, with 72% attributable to hospitalizations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: